• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Part time sales opportunity

As the pharmaceutical business continues to contract, with higher sales targets and tighter bonus structures, we look to other means of income to support our personal growth. These opportunities come in different ways, such as lab sales, device sales and marketing gigs. We have seen many nefarious individuals insert themselves in these arenas over the last five plus years, often stealing time and money from the unwary sales rep.
We continue to grow in the medical services sector by offering opportunities that pay up front without having to wait for cryptic reports that poorly explain what truly occurred in the claim adjudication process. One solution that we have is lab services (blood, carrier testing, urine and saliva toxicology, urine cancer screening, respiratory pathogen panel testing, tissue/path, allergy). We own our contracts and control the billing for all of our labs. This allows us to guarantee payment. Currently, we are in all states but AL and NY (soon, NY will be in network). In addition, we have the largest payor mix of State Medicaid plans (most people will not pay on these products).
Another big sector that we have covered is a brand new anti-aging compound. Our product is the only one in the market with its own NDC. The soft launch in the Spring of this year exceeded expectations by 900%. Two reps who started with us in January (part-time) are making in excess of $75,000/month already.
Lab sales is not dead...it is transforming. We have a full legal and support staff to help you navigate the industry.
 




Dear Staff at Winco Solutions: Re: Strong Interest here,
As an Experienced Medical and Pharma Sales rep., I would like to know more about about sales positions for your new new anti-aging compound. Please reply to fperroni@aol.com
Thank you for your work and reply to further the conversation.
FP